Breath octane and acetaldehyde as markers for acute respiratory distress syndrome in invasively ventilated patients suspected to have ventilator-associated pneumonia.

Nanon F L HeijnenLaura A HagensFrederik-Jan van SchootenLieuwe D J BosIwan C C van der HorstAlex MommersMarcus J SchultzMarry R SmitDennis C J J BergmansAgnieszka SmolinskaRonny M Schnabel

Published in: ERJ open research (2022)

Patients suspected to have VAP with ARDS had a higher acetaldehyde concentration in exhaled breath than patients suspected to have VAP without ARDS. However, in this patient population, discrimination of these breath biomarkers for ARDS was poor, indicating the difficulty of translating diagnostic tests between clinical settings.

Keyphrases

acute respiratory distress syndrome
end stage renal disease
extracorporeal membrane oxygenation
ejection fraction
chronic kidney disease
newly diagnosed
mechanical ventilation
pulmonary embolism
intensive care unit